{"id":5413,"date":"2021-12-22T16:47:11","date_gmt":"2021-12-22T13:47:11","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=5413"},"modified":"2021-12-23T16:49:53","modified_gmt":"2021-12-23T13:49:53","slug":"fda-covid-19-tedavisinde-bir-oral-antivirale-ilk-kez-acil-kullanim-izni-verdi","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/fda-covid-19-tedavisinde-bir-oral-antivirale-ilk-kez-acil-kullanim-izni-verdi\/","title":{"rendered":"FDA, COVID-19 Tedavisinde Bir Oral Antivirale \u0130lk Kez Acil Kullan\u0131m \u0130zni Verdi"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-86785 alignleft\" src=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2020\/01\/FDA_.png\" alt=\"\" width=\"41\" height=\"41\" \/><strong>ABD G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA), Pfizer&#8217;in COVID-19&#8217;a kar\u015f\u0131 geli\u015ftirilen oral antiviral ila\u00e7 Paxlovid i\u00e7in acil kullan\u0131m izni (EUA) yay\u0131mlad\u0131.<\/strong><\/p>\n<p>FDA, SARS-CoV-2 test sonucu pozitif olan ve hastaneye yat\u0131\u015f veya \u00f6l\u00fcm dahil olmak \u00fczere ciddi koronavirus hastal\u0131\u011f\u0131 (COVID-19) ge\u00e7irme riski y\u00fcksek\u00a0 yeti\u015fkinlerde ve pediatrik hastalarda (12 ya\u015f ve \u00fczeri ve en az 40 kg) hafif-orta \u015fiddette COVID-19 tedavisinde kullan\u0131lmak \u00fczere Pfizer&#8217;in Paxlovid adl\u0131 oral antivirali i\u00e7in acil kullan\u0131m izni (EUA) yay\u0131mlad\u0131. Paxlovid sadece re\u00e7eteyle al\u0131nabilir ve COVID-19 tan\u0131s\u0131 konulduktan sonra m\u00fcmk\u00fcn olan en k\u0131sa s\u00fcrede ve semptomlar\u0131n ba\u015flamas\u0131ndan sonraki be\u015f g\u00fcn i\u00e7inde ba\u015flanmal\u0131d\u0131r.<\/p>\n<p>Paxlovid, COVID-19&#8217;un temas \u00f6ncesi veya temas sonras\u0131 \u00f6nlenmesi veya ciddi veya kritik COVID-19 nedeniyle hastaneye yat\u0131r\u0131lmas\u0131 gereken ki\u015filerin tedavisi i\u00e7in yetkilendirilmemi\u015ftir. Paxlovid&#8217;in, COVID-19 a\u015f\u0131s\u0131 ve rapel doz tavsiye edilen ki\u015filerde a\u015f\u0131 yerine ge\u00e7mez. FDA, halk\u0131 a\u015f\u0131 olmaya ve uygunsa takviye doz olmaya \u00e7a\u011f\u0131r\u0131yor.<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19\"><strong>Haber \u0130\u00e7in T\u0131klay\u0131n\u0131z<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ABD G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA), Pfizer&#8217;in COVID-19&#8217;a kar\u015f\u0131 geli\u015ftirilen oral antiviral ila\u00e7 Paxlovid i\u00e7in acil kullan\u0131m izni (EUA) yay\u0131mlad\u0131. FDA, SARS-CoV-2 test sonucu pozitif olan ve hastaneye yat\u0131\u015f veya \u00f6l\u00fcm dahil olmak \u00fczere ciddi koronavirus hastal\u0131\u011f\u0131 (COVID-19) ge\u00e7irme riski y\u00fcksek\u00a0 yeti\u015fkinlerde ve pediatrik hastalarda (12 ya\u015f ve \u00fczeri ve en az 40 kg) hafif-orta \u015fiddette COVID-19 tedavisinde kullan\u0131lmak \u00fczere Pfizer&#8217;in Paxlovid adl\u0131 oral antivirali i\u00e7in acil kullan\u0131m izni (EUA) yay\u0131mlad\u0131. Paxlovid sadece re\u00e7eteyle al\u0131nabilir ve COVID-19 tan\u0131s\u0131 konulduktan sonra m\u00fcmk\u00fcn olan en k\u0131sa s\u00fcrede ve semptomlar\u0131n ba\u015flamas\u0131ndan sonraki be\u015f g\u00fcn i\u00e7inde ba\u015flanmal\u0131d\u0131r. Paxlovid, COVID-19&#8217;un temas \u00f6ncesi veya temas sonras\u0131 [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5414,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5413"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=5413"}],"version-history":[{"count":1,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5413\/revisions"}],"predecessor-version":[{"id":5415,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5413\/revisions\/5415"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/5414"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=5413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=5413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=5413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}